グローバル過敏性腸症候群の治療薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Irritable Bowel Syndrome Drug - Global Top Players Market Share and Ranking 2026

レポートID：
223814
発表時期：
2026-03-03
レポート形式：
PDF
産業カテゴリー：
薬品及びサプリメント
レポート言語：
英語、日本語
ページ数：
87
発行会社（調査会社）：
YHResearch

レポートの概要

本報告書は、世界の過敏性腸症候群の治療薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から過敏性腸症候群の治療薬市場を分析し、需要構造と成長特性を明確化します。
過敏性腸症候群の治療薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、過敏性腸症候群の治療薬に関する的確な意思決定を行うための実践的なインサイトを提供します。

 主要過敏性腸症候群の治療薬市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは過敏性腸症候群の治療薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
過敏性腸症候群の治療薬市場の主要企業には以下が含まれます：
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan 

製品別
IBS-D Drugs
IBS-C Drugs
Others 

アプリケーション別
Women
Men 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
過敏性腸症候群の治療薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
過敏性腸症候群の治療薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に過敏性腸症候群の治療薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に過敏性腸症候群の治療薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、過敏性腸症候群の治療薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、過敏性腸症候群の治療薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
過敏性腸症候群の治療薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 過敏性腸症候群の治療薬市場の全体像と成長見通し
過敏性腸症候群の治療薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が過敏性腸症候群の治療薬市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
過敏性腸症候群の治療薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
過敏性腸症候群の治療薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から過敏性腸症候群の治療薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
過敏性腸症候群の治療薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
過敏性腸症候群の治療薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします

Description

According to YH Research, the global market for Irritable Bowel Syndrome Drug should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.

By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Irritable Bowel Syndrome Drug market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Irritable Bowel Syndrome Drug market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.

By segment, Women grew percent to account for percent of the total market sales, and Men grew percent.

This report studies and analyses global Irritable Bowel Syndrome Drug status and future trends, to help determine the Irritable Bowel Syndrome Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Irritable Bowel Syndrome Drug market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Irritable Bowel Syndrome Drug by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Irritable Bowel Syndrome Drug by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Irritable Bowel Syndrome Drug key consuming regions, consumption value and demand structure
(5) Irritable Bowel Syndrome Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Ironwood Pharmaceuticals
    Bausch Health
    Takeda
    Sebela Pharmaceuticals
    Allergan

Market segment by Type, covers
    IBS-D Drugs
    IBS-C Drugs
    Others

Market segment by Application, can be divided into
    Women
    Men

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Irritable Bowel Syndrome Drug product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Irritable Bowel Syndrome Drug market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Irritable Bowel Syndrome Drug market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Irritable Bowel Syndrome Drug industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions

Table of Contents

1 Market Overview
    1.1 Irritable Bowel Syndrome Drug Definition
    1.2 Global Irritable Bowel Syndrome Drug Market Size and Forecast
    1.3 Japan Irritable Bowel Syndrome Drug Market Size and Forecast
    1.4 Share of Japan Irritable Bowel Syndrome Drug Market with Respect to the Global Market
    1.5 Irritable Bowel Syndrome Drug Market Size: Japan VS Global Growth Rate, 2021-2032
    1.6 Irritable Bowel Syndrome Drug Market Dynamics
        1.6.1 Irritable Bowel Syndrome Drug Market Drivers
        1.6.2 Irritable Bowel Syndrome Drug Market Restraints
        1.6.3 Irritable Bowel Syndrome Drug Industry Trends
        1.6.4 Irritable Bowel Syndrome Drug Industry Policy

2 Global Leading Players and Market Share
    2.1 By Revenue of Irritable Bowel Syndrome Drug, Global Market Share by Company, 2021-2026
    2.2 Global Irritable Bowel Syndrome Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Irritable Bowel Syndrome Drug Concentration Ratio
    2.4 Global Irritable Bowel Syndrome Drug Mergers & Acquisitions, Expansion Plans
    2.5 Global Irritable Bowel Syndrome Drug Major Companies Product Type
    2.6 Head Office and Area Served of Key Players

3 Japan Leading Players, Market Share and Ranking
    3.1 By Revenue of Irritable Bowel Syndrome Drug, Japan Market Share by Company, 2021-2026
    3.2 Japan Irritable Bowel Syndrome Drug Irritable Bowel Syndrome Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
    4.1 Irritable Bowel Syndrome Drug Industry Chain
    4.2 Irritable Bowel Syndrome Drug Upstream Analysis
        4.2.1 Irritable Bowel Syndrome Drug Core Raw Materials
        4.2.2 Main Manufacturers of Irritable Bowel Syndrome Drug Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Irritable Bowel Syndrome Drug Production Mode
    4.6 Irritable Bowel Syndrome Drug Procurement Model
    4.7 Irritable Bowel Syndrome Drug Industry Sales Model and Sales Channels
        4.7.1 Irritable Bowel Syndrome Drug Sales Model
        4.7.2 Irritable Bowel Syndrome Drug Typical Distributors

5 Sights by Type
    5.1 Irritable Bowel Syndrome Drug Classification by Type
        5.1.1 IBS-D Drugs
        5.1.2 IBS-C Drugs
        5.1.3 Others
    5.2 by Type, Global Irritable Bowel Syndrome Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032
    5.3 by Type, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032

6 Sights by Application
    6.1 Irritable Bowel Syndrome Drug Segment by Application
        6.1.1 Women
        6.1.2 Men
    6.2 by Application, Global Irritable Bowel Syndrome Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Application, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032

7 Sales Sights by Region
    7.1 By Region, Global Irritable Bowel Syndrome Drug Consumption Value, 2021 VS 2025 VS 2032
    7.2 By Region, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032
    7.3 North America
        7.3.1 North America Irritable Bowel Syndrome Drug Market Size & Forecasts, 2021-2032
        7.3.2 By Country, North America Irritable Bowel Syndrome Drug Market Size Market Share
    7.4 Europe
        7.4.1 Europe Irritable Bowel Syndrome Drug Market Size & Forecasts, 2021-2032
        7.4.2 By Country, Europe Irritable Bowel Syndrome Drug Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Irritable Bowel Syndrome Drug Market Size & Forecasts, 2021-2032
        7.5.2 By Country/Region, Asia Pacific Irritable Bowel Syndrome Drug Market Size Market Share
    7.6 South America
        7.6.1 South AmericaIrritable Bowel Syndrome Drug Market Size & Forecasts, 2021-2032
        7.6.2 By Country, South America Irritable Bowel Syndrome Drug Market Size Market Share
    7.7 Middle East & Africa

8 Sales Sights by Country Level
    8.1 By Country, Global Irritable Bowel Syndrome Drug Market Size & CAGR, 2021 VS 2025 VS 2032
    8.2 By Country, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032
    8.3 United States
        8.3.1 United States Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.3.2 by Type, United States Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.3.3 by Application, United States Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.4 Europe
        8.4.1 Europe Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.4.2 by Type, Europe Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.4.3 by Application, Europe Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.5 China
        8.5.1 China Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.5.2 by Type, China Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.5.3 by Application, China Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.6 Japan
        8.6.1 Japan Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.6.2 by Type, Japan Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.6.3 by Application, Japan Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.7 South Korea
        8.7.1 South Korea Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.7.2 by Type, South Korea Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.7.3 by Application, South Korea Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.8 Southeast Asia
        8.8.1 Southeast Asia Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.8.2 by Type, Southeast Asia Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.8.3 by Application, Southeast Asia Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.9 India
        8.9.1 India Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.9.2 by Type, India Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.9.3 by Application, India Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Irritable Bowel Syndrome Drug Market Size, 2021-2032
        8.10.2 by Type, Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
        8.10.3 by Application, Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032

9 Company Profile
    9.1 Ironwood Pharmaceuticals
        9.1.1 Ironwood Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Ironwood Pharmaceuticals Company Profile and Main Business
        9.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Models, Specifications, and Application
        9.1.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue and Gross Margin, 2021-2026
        9.1.5 Ironwood Pharmaceuticals Recent Developments
    9.2 Bausch Health
        9.2.1 Bausch Health Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Bausch Health Company Profile and Main Business
        9.2.3 Bausch Health Irritable Bowel Syndrome Drug Models, Specifications, and Application
        9.2.4 Bausch Health Irritable Bowel Syndrome Drug Revenue and Gross Margin, 2021-2026
        9.2.5 Bausch Health Recent Developments
    9.3 Takeda
        9.3.1 Takeda Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Takeda Company Profile and Main Business
        9.3.3 Takeda Irritable Bowel Syndrome Drug Models, Specifications, and Application
        9.3.4 Takeda Irritable Bowel Syndrome Drug Revenue and Gross Margin, 2021-2026
        9.3.5 Takeda Recent Developments
    9.4 Sebela Pharmaceuticals
        9.4.1 Sebela Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Sebela Pharmaceuticals Company Profile and Main Business
        9.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Models, Specifications, and Application
        9.4.4 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue and Gross Margin, 2021-2026
        9.4.5 Sebela Pharmaceuticals Recent Developments
    9.5 Allergan
        9.5.1 Allergan Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Allergan Company Profile and Main Business
        9.5.3 Allergan Irritable Bowel Syndrome Drug Models, Specifications, and Application
        9.5.4 Allergan Irritable Bowel Syndrome Drug Revenue and Gross Margin, 2021-2026
        9.5.5 Allergan Recent Developments

10 Conclusion

11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer

Table of Figures

List of Tables
Table 1. Irritable Bowel Syndrome Drug Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
Table 2. Irritable Bowel Syndrome Drug Market Restraints
Table 3. Irritable Bowel Syndrome Drug Market Trends
Table 4. Irritable Bowel Syndrome Drug Industry Policy
Table 5. Global Irritable Bowel Syndrome Drug Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 6. Global Irritable Bowel Syndrome Drug Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 7. Global Irritable Bowel Syndrome Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Irritable Bowel Syndrome Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Irritable Bowel Syndrome Drug Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. Japan Irritable Bowel Syndrome Drug Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 12. Japan Irritable Bowel Syndrome Drug Revenue Market Share by Company, 2021-2026
Table 13. Global Key Players of Irritable Bowel Syndrome Drug Upstream (Raw Materials)
Table 14. Global Irritable Bowel Syndrome Drug Typical Customers
Table 15. Irritable Bowel Syndrome Drug Typical Distributors
Table 16. by Type, Global Irritable Bowel Syndrome Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 17. by Application, Global Irritable Bowel Syndrome Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 18. By Region, Global Irritable Bowel Syndrome Drug Consumption Value, 2021 VS 2025 VS 2032, US$ Million
Table 19. By Region, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Table 20. By Country, Global Irritable Bowel Syndrome Drug Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 21. By Country, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Table 22. By Country, Global Irritable Bowel Syndrome Drug Consumption Value Market Share, 2021-2032
Table 23. Ironwood Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 24. Ironwood Pharmaceuticals Company Profile and Main Business
Table 25. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Models, Specifications, and Application
Table 26. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue and Gross Margin, US$ Million, 2021-2026
Table 27. Ironwood Pharmaceuticals Recent Developments
Table 28. Bausch Health Company Information, Head Office, Market Area, and Industry Position
Table 29. Bausch Health Company Profile and Main Business
Table 30. Bausch Health Irritable Bowel Syndrome Drug Models, Specifications, and Application
Table 31. Bausch Health Irritable Bowel Syndrome Drug Revenue and Gross Margin, US$ Million, 2021-2026
Table 32. Bausch Health Recent Developments
Table 33. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 34. Takeda Company Profile and Main Business
Table 35. Takeda Irritable Bowel Syndrome Drug Models, Specifications, and Application
Table 36. Takeda Irritable Bowel Syndrome Drug Revenue and Gross Margin, US$ Million, 2021-2026
Table 37. Takeda Recent Developments
Table 38. Sebela Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 39. Sebela Pharmaceuticals Company Profile and Main Business
Table 40. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Models, Specifications, and Application
Table 41. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue and Gross Margin, US$ Million, 2021-2026
Table 42. Sebela Pharmaceuticals Recent Developments
Table 43. Allergan Company Information, Head Office, Market Area, and Industry Position
Table 44. Allergan Company Profile and Main Business
Table 45. Allergan Irritable Bowel Syndrome Drug Models, Specifications, and Application
Table 46. Allergan Irritable Bowel Syndrome Drug Revenue and Gross Margin, US$ Million, 2021-2026
Table 47. Allergan Recent Developments

List of Figures
Figure 1. Irritable Bowel Syndrome Drug Picture
Figure 2. Global Irritable Bowel Syndrome Drug Consumption Value, (US$ million) & (2021-2032)
Figure 3. Japan Irritable Bowel Syndrome Drug Consumption Value, (US$ million) & (2021-2032)
Figure 4. By Consumption Value, Japan Irritable Bowel Syndrome Drug Market Share of Global, 2021-2032
Figure 5. Global Irritable Bowel Syndrome Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
Figure 6. Japan Irritable Bowel Syndrome Drug Key Participants, Market Share, 2025
Figure 7. Irritable Bowel Syndrome Drug Industry Chain
Figure 8. Irritable Bowel Syndrome Drug Procurement Model
Figure 9. Irritable Bowel Syndrome Drug Sales Model
Figure 10. Irritable Bowel Syndrome Drug Sales Channels, Direct Sales, and Distribution
Figure 11. IBS-D Drugs
Figure 12. IBS-C Drugs
Figure 13. Others
Figure 14. by Type, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 15. by Type, Global Irritable Bowel Syndrome Drug Consumption Value Market Share, 2021-2032
Figure 16. Women
Figure 17. Men
Figure 18. by Application, Global Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 19. by Application, Global Irritable Bowel Syndrome Drug Revenue Market Share, 2021-2032
Figure 20. By Region, Global Irritable Bowel Syndrome Drug Consumption Value Market Share, 2021-2032
Figure 21. North America Irritable Bowel Syndrome Drug Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 22. By Country, North America Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025
Figure 23. Europe Irritable Bowel Syndrome Drug Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 24. By Country, Europe Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025
Figure 25. Asia Pacific Irritable Bowel Syndrome Drug Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 26. By Country/Region, Asia Pacific Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025
Figure 27. South America Irritable Bowel Syndrome Drug Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 28. By Country, South America Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025
Figure 29. Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 30. United States Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 31. by Type, United States Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 32. by Application, United States Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 33. Europe Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 34. by Type, Europe Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 35. by Application, Europe Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 36. China Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 37. by Type, China Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 38. by Application, China Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 39. Japan Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 40. by Type, Japan Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 41. by Application, Japan Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 42. South Korea Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 43. by Type, South Korea Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 44. by Application, South Korea Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 45. Southeast Asia Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 46. by Type, Southeast Asia Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 47. by Application, Southeast Asia Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 48. India Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 49. by Type, India Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 50. by Application, India Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 51. Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value, 2021-2032, US$ Million
Figure 52. by Type, Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 53. by Application, Middle East & Africa Irritable Bowel Syndrome Drug Consumption Value Market Share, 2025 VS 2032
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up Approaches
Figure 57. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット

購入方法

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）